Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Hydroxychloroquine [118-42-3]
Cat# T9287-500mg
Size : 500mg
Brand : TargetMol
Hydroxychloroquine
Hydroxychloroquine (2-[[4-[(7-Chloroquinolin-4-yl)amino]pentyl](ethyl)amino]ethanol) (HCQ) is an alkalinizing lysosomatropic drug that acts by inducing apoptosis of renal cancer cells in vitro and inhibiting TLR7/9. It is a medication used to prevent and treat malaria, and it's also being studied as an experimental treatment for COVID-19.
Description | Hydroxychloroquine (2-[[4-[(7-Chloroquinolin-4-yl)amino]pentyl](ethyl)amino]ethanol) (HCQ) is an alkalinizing lysosomatropic drug that acts by inducing apoptosis of renal cancer cells in vitro and inhibiting TLR7/9. It is a medication used to prevent and treat malaria, and it's also being studied as an experimental treatment for COVID-19. |
Synonyms | 2-[[4-[(7-Chloroquinolin-4-yl)amino]pentyl](ethyl)amino]ethanol |
Molecular Weight | 335.87 |
Formula | C18H26ClN3O |
CAS No. | 118-42-3 |
Storage
Solubility Information
H2O: 1.65 mg/mL (4.91 mM), Sonification and heating to 60℃ are recommended.
DMSO: < 1 mg/mL (insoluble or slightly soluble)
1M HCl: 99 mg/mL (294.75 mM), when pH is adjusted to 2 with HCl.